Skip to main content
Log in

Interactions of 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)-propoxy]-2(lH)-quinolinone (OPC-4392) with 3H-Spiperone and 3H-SCH 23390 Binding in Rat Striatum: Effects of Lesions

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(lH)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D-2 receptor antagonist (Yasuda et al, Life Sci. 42:1941–1954,1988), was studied for its binding characteristics at 3H-SCH 23390-labeled dopamine D-l receptors and 3H-spiperone-labeled dopamine D-2 receptors in rat striatum. The binding affinity of OPC-4392 for 3H-spiperone-labeled D-2 receptors was 500 times higher than for 3H-SCH 23390-labeled D-l receptors. 6-Hydroxydopamine lesions of striatum and high-frequency current lesions of medial forebrain bundle did not affect the competition of OPC-4392 for 3H-spiperone binding. Kainic acid lesions of striatum significantly changed the one-site model fit to a two-site model fit of the competition curve of OPC-4392 for 3H-spiperone binding, suggesting that OPC-4392 competed with 3H-spiperone binding differently for postsynaptic dopamine D-2 receptors and for presynaptic dopamine autoreceptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. A. Carlsson. In E. Usdin and W. E. Bunney (eds.), Pre-and Postsynaptic Receptors, Marcel Dekker, New York, 1975, p. 49.

    Google Scholar 

  2. G. Di Chiara, M. L. Porceddu, L. Vargiu, A. Argiolas, and G. L. Gessa. Nature 264:564–566 (1976).

    Google Scholar 

  3. G. K. Aghajanian and B. S. Bunney. Naunyn-Schmiedeberg Arch. Pharmacol. 297:1–7 (1977).

    Google Scholar 

  4. K. Starke, W. Reimann, A. Zumstein, and G. Hertting. Naunyn-Schmiedeberg Arch. Pharmacol. 305:27–36 (1978).

    Google Scholar 

  5. S. Arbilla and S. Z. Langer. Eur. J. Pharmacol. 76:345–351 (1981).

    Google Scholar 

  6. M. Morelli, E. Carboni, S. Devoto, and G. Di Chiara. Eur. J. Pharmacol. 140:99–104 (1987).

    Google Scholar 

  7. F. M. Filloux, J. K. Wamsley, and T. M. Dawson. Eur. J. Pharmacol. 138:61–68 (1987).

    Google Scholar 

  8. Y. Yasuda, T. Kikuchi, S. Suzuki, M. Tsutsui, K. Yamada, and T. Hiyama. Life Sci. 42:1941–1954 (1988).

    Google Scholar 

  9. I. Creese and E. J. Hess. In R. A. O'Brien (ed.), Clinical Pharmacology, Vol. 5. Receptor Binding in Drug Research, Marcel Dekker, New York and Basel, 1986, pp. 123–149.

    Google Scholar 

  10. W. Billard, V. Ruperto, G. Crosby, L. C. Iorio, and A. Barnett. Life Sci. 35:1885–1893 (1984).

    Google Scholar 

  11. U. Ungerstedt. Acta Physiol. Scand. Suppl. 367 (1971).

  12. I. Creese, D. R. Burt, and S. H. Synder. Science 197:596–598 (1977).

    Google Scholar 

  13. I. C. Murrin, K. Gale, and M. J. Kuhar. Eur. J. Pharmacol. 60:229–235 (1977).

    Google Scholar 

  14. R. Schwarcz and J. T. Coyle. Brain Res 127:235–249 (1977).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, X., Nakata, Y., Kikuchi, T. et al. Interactions of 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)-propoxy]-2(lH)-quinolinone (OPC-4392) with 3H-Spiperone and 3H-SCH 23390 Binding in Rat Striatum: Effects of Lesions. Pharm Res 7, 280–282 (1990). https://doi.org/10.1023/A:1015882314302

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015882314302

Navigation